Reply to: "PCSK9 antagonists and inflammation"

Atherosclerosis. 2018 Jan:268:237-238. doi: 10.1016/j.atherosclerosis.2017.11.014. Epub 2017 Nov 21.
No abstract available

Keywords: Atherosclerotic cardiovascular disease; Inflammation; PCSK9; PCSK9 inhibitors.

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Inflammation*
  • Proprotein Convertase 9*

Substances

  • PCSK9 protein, human
  • Proprotein Convertase 9